Ono Pharmaceutical

Ono to Acquire Deciphera for $2.4 Billion

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer therapeutics, and specializes in kinase biology.

News

Merck Settles Keytruda Patent Disputes

News

Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Virtual Event

Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Ono Pharmaceutical

Ono to Acquire Deciphera for $2.4 Billion

Merck Settles Keytruda Patent Disputes

Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

Top-Feature

API Manufacturing

Advanced Recycling Conference 2025: New Paths to the Circular Economy

A successful concept on course for expansion — maintenance Munich 2025

20 Years of CHEManager International

Brenntag Downsizes Management Board, Retains Both Divisions

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Virtual Event

Downstream Purification

Newsletter & e-edition